Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported in Stroke: Journal of the American Heart Association.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
In the largest study of its kind, Mayo Clinic researchers have shown that women who had one or both ovaries removed before menopause faced an increased long-term risk of cognitive impairment or dementia, compared to women who retained their ovaries.
University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip replacement, dental reconstruction and vascular stenting.
People who stopped taking cholesterol-lowering drugs after being hospitalized for a stroke are at greater risk of death or dependency within three months of the stroke, according to a study published in the Aug. 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
For most children and teens, the beginning of a new school year is just around the corner. Not only will they be hitting the books again after a three-month-long summer break, but many of them will also participate in after-school activities. More research is emerging that sheds light on a serious problem affecting student-athletes nationwide: the number of children and teens who are considered obese is rising dramatically.
The City of Houston is taking action to protect Houstonians from the substantial health risks associated with secondhand smoke. The City Council has passed an ordinance that will make all workplaces and public spaces smoke free starting September 1, 2007.
The UK urgently needs to reorganise stroke services to improve outcomes for patients, argues a senior doctor in this week?s BMJ.
A neuroscientist working at University College London has devised the first experimental method to induce an out-of-body experience in healthy participants. In a paper published today in Science, Dr. Henrik Ehrsson, UCL Institute of Neurology, outlines the unique method by which the illusion is created and the implications of its discovery.
Using genetic engineering, researchers have created an obsessive-compulsive disorder (OCD) – like set of behaviors in mice and reversed them with antidepressants and genetic targeting of a key brain circuit.